Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study - PubMed (original) (raw)
Multicenter Study
. 2004 Oct;53(10):2623-32.
doi: 10.2337/diabetes.53.10.2623.
Affiliations
- PMID: 15448093
- DOI: 10.2337/diabetes.53.10.2623
Multicenter Study
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study
Anthony J G Hanley et al. Diabetes. 2004 Oct.
Abstract
A limited number of studies have reported associations of markers of liver injury, including elevated concentrations of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), with prospective risk of type 2 diabetes. However, only one study has adjusted for a detailed measure of insulin sensitivity (insulin sensitivity index [S(i)]), which is important given associations of obesity and S(i) with nonalcoholic fatty liver disease (NAFLD). Our objective was to investigate the associations of elevated AST and ALT with incident type 2 diabetes among 906 participants in the Insulin Resistance Atherosclerosis Study who were nondiabetic at baseline. S(i) and acute insulin response (AIR) were measured directly from the frequently sampled intravenous glucose tolerance test among black, Hispanic, and non-Hispanic white participants aged 40-69 years. After 5.2 years, 148 individuals had developed type 2 diabetes. Baseline AST and ALT were positively correlated with fasting insulin (r = 0.22 and r = 0.35, respectively), waist circumference (r = 0.18 and r = 0.34), and fasting glucose (r = 0.13 and r = 0.29) and inversely with S(i) (r = -0.18 and r = -0.30; all P < 0.0001). In separate logistic regression models adjusting for age, sex, ethnicity, clinical center, and alcohol consumption, participants in the highest quartiles (Q4) of AST and ALT were at significantly increased risk of incident type 2 diabetes compared with those in the lowest three quartiles (Q1-Q3): AST: odds ratio (OR) 1.73 (95% CI 1.17-2.57); ALT: OR 2.32 (1.36-3.75). After further adjustment for smoking, waist circumference, triglyceride, HDL, impaired glucose tolerance, S(i), and AIR, both AST and ALT remained significantly associated with incident type 2 diabetes: AST, Q4 vs. Q1-Q3: OR 1.98 (1.23-3.17); ALT, Q4 vs. Q1-Q3: OR 2.00 (1.22-3.28). There were no interactions of sex, ethnicity, obesity, impaired glucose tolerance, or S(i) with AST or ALT in the prediction of type 2 diabetes. When entered into the same model with adjustment for demographic variables, both C-reactive protein and ALT independently predicted type 2 diabetes. In addition, AST and ALT were positively associated with incident type 2 diabetes after excluding former and moderate to heavy drinkers. In conclusion, AST and ALT independently predict type 2 diabetes. Baseline elevations of these markers may reflect NAFLD or related pathologies.
Similar articles
- Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Hanley AJ, et al. Diabetes. 2005 Nov;54(11):3140-7. doi: 10.2337/diabetes.54.11.3140. Diabetes. 2005. PMID: 16249437 - High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. Vozarova B, et al. Diabetes. 2002 Jun;51(6):1889-95. doi: 10.2337/diabetes.51.6.1889. Diabetes. 2002. PMID: 12031978 - Associations of White Blood Cell Count,Alanine Aminotransferase,and Aspartate Aminotransferase in the First Trimester withGestational Diabetes Mellitus.
Zhao LL, Li W, Ping F, Ma LK, Nie M. Zhao LL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Jun 10;38(3):283-7. doi: 10.3881/j.issn.1000-503X.2016.03.007. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27469912 - AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.
Liu Y, Zhao P, Cheng M, Yu L, Cheng Z, Fan L, Chen C. Liu Y, et al. Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review. - Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis.
Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, Wang W, Zhou X, Zhang M, Sun X. Zhang L, et al. Sci Rep. 2016 Sep 6;6:32649. doi: 10.1038/srep32649. Sci Rep. 2016. PMID: 27596383 Free PMC article. Review.
Cited by
- Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.
Dickson JC, Liese AD, Lorenzo C, Haffner SM, Watkins SM, Hamren SJ, Stiles JK, Wagenknecht LE, Hanley AJ. Dickson JC, et al. BMC Gastroenterol. 2015 Jul 28;15:88. doi: 10.1186/s12876-015-0321-3. BMC Gastroenterol. 2015. PMID: 26215323 Free PMC article. - Obesity, insulin resistance and their interaction on liver enzymes.
Liu C, Shao M, Lu L, Zhao C, Qiu L, Liu Z. Liu C, et al. PLoS One. 2021 Apr 21;16(4):e0249299. doi: 10.1371/journal.pone.0249299. eCollection 2021. PLoS One. 2021. PMID: 33882064 Free PMC article. - Serum alkaline phosphatase levels and the risk of new-onset diabetes in hypertensive adults.
Zhang Y, Zhou C, Li J, Zhang Y, Xie D, Liang M, Wang B, Song Y, Wang X, Huo Y, Hou FF, Xu X, Qin X. Zhang Y, et al. Cardiovasc Diabetol. 2020 Oct 24;19(1):186. doi: 10.1186/s12933-020-01161-x. Cardiovasc Diabetol. 2020. PMID: 33099298 Free PMC article. Clinical Trial. - Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound.
Esteghamati A, Jamali A, Khalilzadeh O, Noshad S, Khalili M, Zandieh A, Morteza A, Nakhjavani M. Esteghamati A, et al. Diabetol Metab Syndr. 2010 Nov 3;2:65. doi: 10.1186/1758-5996-2-65. Diabetol Metab Syndr. 2010. PMID: 21047423 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- DK-29867/DK/NIDDK NIH HHS/United States
- M01-RR-43/RR/NCRR NIH HHS/United States
- R01 58329/PHS HHS/United States
- U01-HL47887/HL/NHLBI NIH HHS/United States
- U01-HL47889/HL/NHLBI NIH HHS/United States
- U01-HL47892/HL/NHLBI NIH HHS/United States
- U01-HL47902/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials